Verve Therapeutics
VERV
#7368
Rank
S$0.46 B
Marketcap
$5.18
Share price
-6.65%
Change (1 day)
-70.03%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.32

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.26. In 2022 the company made an earnings per share (EPS) of -$3.92 a decrease over its 2021 EPS that were of -$3.39.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.3210.27%
2022-$3.9215.54%
2021-$3.3961.32%
2020-$2.10